Allo-HCT With Unrelated Donor Tied to Better Outcomes in AML

TUESDAY, June 4, 2019 -- Allogeneic hematopoietic cell transplantation (allo-HCT) with an unrelated donor (UD) results in better transplantation outcomes than cord blood transplantation (CBT) in acute myeloid leukemia (AML) patients with active...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news